Biosimilars Report Issue 2, Clinician and Payer Perspectives

The second issue highlights the clincian and payer perspectives on the first biosimilar approved in the US, by Dr. Gary H. Lyman and Dr. Edward Pezalla.
 
 

podcast icon  
Podcast:
Clinician and Payer Perspectives on the First Biosimilar Approved in the US

Listen to Gary H. Lyman, MD, MPH and Edward Pezalla, MD, MPH and learn about the Clinician and Payer Perspectives on the First Biosimilar Approved in the US.

Play

 

webinars  
Webinar:
Biosimilars on the Horizon in the US: A Review of What's Coming and the European Experience

Watch Dr. James Stevenson discuss Biosimilars on the Horizon in the US: A Review of What's Coming and the European Experience

Play

 

webinars  
Request a Live Meeting

Which of the Following Best Describes Your Need for Education Related to Biosimilars?
 

survey results

Over 85% of health care professionals would like to learn more about Biologics and Biosimilars. 96% of participants agreed that participating in a live meeting will improve their patients outcomes.

Support available for Grand Rounds, Chapter Meetings, and other gatherings.

Request a Live Meeting

 

biosimilars survey  
Survey Question:
Which of the Following Best Describes Your Need for Education Related to Biosimilars

New & Noteworthy